Shepherd Kaplan Krochuk’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
– Sell
-21,700
Closed -$1.36M – 287
2017
Q1
$1.43M Buy
+21,700
New +$1.49M 0.74% 25
2016
Q4
– Sell
-7,632
Closed -$547K – 391
2016
Q3
$538K Hold
7,632
– – 0.11% 124
2016
Q2
$579K Sell
7,632
-2,432
-24% -$179K 0.14% 98
2016
Q1
$691K Sell
10,064
-959
-9% -$68.9K 0.21% 78
2015
Q4
$964K Sell
11,023
-892
-7% -$76.4K 0.25% 61
2015
Q3
$965K Sell
11,915
-100
-0.8% -$8.71K 0.26% 67
2015
Q2
$1.07M Buy
12,015
+10
+0.1% +$874 0.2% 85
2015
Q1
$1.04M Hold
12,005
– – 0.18% 98
2014
Q4
$1.02M Sell
12,005
-2,000
-14% -$156K 0.16% 130
2014
Q3
$989K Buy
14,005
+90
+0.6% +$6.41K 0.13% 135
2014
Q2
$965K Hold
13,915
– – 0.1% 150
2014
Q1
$1.04M Hold
13,915
– – 0.12% 136
2013
Q4
$977K Hold
13,915
– – 0.12% 143
2013
Q3
$860K Hold
13,915
– – 0.14% 144
2013
Q2
$859K Buy
+13,915
New +$838K 0.17% 127

Other funds holding ESRX

Shepherd Kaplan Krochuk's ESRX Position: Q2 2017 in Review

Shepherd Kaplan Krochuk sold out of Express Scripts Holding Company (ESRX) in Q2 2017, closing a stake of 21,700 shares — an estimated $1.36M sold.

Shepherd Kaplan Krochuk first reported a position in ESRX in Q2 2013 and held it in 15 quarters. The position peaked at $1.43M in Q1 2017. 1,046 funds tracked by Wall St. Rank hold ESRX as of Q2 2017.

  • Shepherd Kaplan Krochuk reported no remaining Express Scripts Holding Company position as of Q2 2017 after selling out during the quarter.
  • Shepherd Kaplan Krochuk sold 21,700 Express Scripts Holding Company shares in Q2 2017, an estimated $1.36M.
  • Shepherd Kaplan Krochuk first reported a position in Express Scripts Holding Company in Q2 2013 and held it in 15 quarters.
  • Shepherd Kaplan Krochuk's Express Scripts Holding Company position peaked at $1.43M in Q1 2017.
  • 1,046 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q2 2017.

Based on Shepherd Kaplan Krochuk's 13F filing for Q2 2017, filed 10 Aug 2017.